1. Home
  2. PULM vs MLEC Comparison

PULM vs MLEC Comparison

Compare PULM & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$1.68

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$5.80

Market Cap

5.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PULM
MLEC
Founded
2003
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.0M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
PULM
MLEC
Price
$1.68
$5.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 41.9K
20.4K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 46.18
N/A
EPS
N/A
★ N/A
Revenue
★ $7,910,000.00
N/A
Revenue This Year
N/A
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5069.93
N/A
52 Week Low
$1.16
$0.21
52 Week High
$5.50
$23.22

Technical Indicators

Market Signals
Indicator
PULM
MLEC
Relative Strength Index (RSI) 58.66 37.53
Support Level $1.61 $5.41
Resistance Level $1.66 $9.23
Average True Range (ATR) 0.10 0.74
MACD 0.03 -0.10
Stochastic Oscillator 67.27 4.78

Price Performance

Historical Comparison
PULM
MLEC

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: